Translational Pathways for Cardiovascular Devices – Session V: Current Challenges and Future Direction for Catheter Ablation Development and Iteration: FDA Point of View – Mark Fellman Practice Quiz
Time limit: 0
Quiz Summary
0 of 3 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Quiz complete. Results are being recorded.
Results
Time has elapsed
Categories
Not categorized0%
You have completed the practice quiz, please continue on to the next session.
1
2
3
Current
Review
Answered
Correct
Incorrect
Question 1 of 3
1. Question
Currently in the US there are many approved ablation catheters for persistent atrial fibrillation
Correct
Incorrect
Question 2 of 3
2. Question
Which of the following is incorrect regarding the role of the regulatory agency in innovation?
Correct
Incorrect
Question 3 of 3
3. Question
In evaluating arrhythmia therapy, the FDA allows the synthesizing of data from different sources including clinical registries and electronic health records from both the US and Europe